IBX
Imagion Biosystems Limited
1 day chart
About IBX
Imagion Biosystems is developing a new non-radioactive and precision diagnostic molecular imaging technology. Combining biotechnology and nanotechnology, the Company aims to detect cancer and other diseases earlier and with higher specificity than is currently possible.
Buy Australian shares starting with IBX. Invest today with a CHESS-sponsored investing platform!
Market Capitalisation
$18M
Price-earnings ratio
-1.61
Dividend yield
NaN%
High today
$0.01
Low today
$0.01
Open price
$0.01
52-week high
$0.04
52-week low
$0.01
Announcements
IBX FAQs
Can I buy IBX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake platform allows you to buy IBX shares and over 8,000 stocks and ETFs across the ASX and Wall St.
How much is one share of Imagion Biosystems Limited?
One share of Imagion Biosystems Limited is valued at $0.01.
What is the ticker symbol for Imagion Biosystems Limited?
The ticker symbol for Imagion Biosystems Limited is IBX.
How do I buy IBX shares in Australia?
To buy IBX stocks in Australia you'll need to open an account with an investing platform like Stake.
To do so follow these steps:
To do so follow these steps:
- Sign up in minutes, all you need is some I.D.
- Choose Stake AUS
- Deposit directly into your Stake wallet and you're ready to invest in IBX
What is the 52-week high for Imagion Biosystems Limited stock?
The Imagion Biosystems Limited 52-week high stock price is $0.04.
What is the 52-week low for Imagion Biosystems Limited stock?
The Imagion Biosystems Limited 52-week low stock price is $0.01.
What is the market capitalisation of Imagion Biosystems Limited IBX?
As of 30/09/2023 Imagion Biosystems Limited has a market cap of $18M.
Related Stocks
This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.